ELAVL2 and neoplasm: In contrast, the expression of ELAVL2, RAD9B and CNOT3, already identified as tumor suppressor [35], and inhibitors of cell cycle progression [36], respectively, were upregulated by the miR-Combo (Fig. 3C).